H2O Health
- Vitamin IV Therapy
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Milwaukee, WI
Milwaukee sits on the western shore of Lake Michigan, the largest city in Wisconsin and a market long shaped by brewing heritage, manufacturing, and healthcare anchors like Froedtert and the Medical College of Wisconsin. The local IV therapy market operates alongside a strong craft beer and festival culture that makes hangover recovery a meaningful seasonal driver, particularly around Summerfest at Henry Maier Festival Park in late June and early July. Clinics cluster in the Third Ward, East Side, Brady Street, and along Bluemound Road in the Wauwatosa medical corridor. Wisconsin Board of Nursing rules allow RNs to place peripheral IVs under physician delegation, and APRNs in Wisconsin practice under a collaborative agreement with prescriptive authority. Long, dark winters drive vitamin D and methylation support demand, and Lake Michigan lake-effect recovery hits hard from November through March.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Wisconsin medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.